NEUMORA THERAPEUTICS INC (NMRA:NASDAQ)
$0.3681 -0.0248 (-6.312%)
Analysed NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) News Sources
Neumora Ends Depression Drug Programme and Announces Workforce Reduction (NMRA)
15-06-2026
advfn.com
NMRA Stock On Track For Worst Day In 1.5 Years — Neumora Therapeutics' Lead Depression Drug Fails Late Stage Trials
15-06-2026
stocktwits.com
Neumora depression drug fails; EnGene to cut 50% of staff
16-06-2026
biopharmadive.com
Three pivotal MDD trial failures for Neumora lead to staffing cuts
16-06-2026
clinicaltrialsarena.com
Why Neumora Therapeutics (NMRA) Faces a Major Catalyst From Navacaprant’s Upcoming Depression Data
17-06-2026
yahoo.com
Why Neumora Therapeutics, Inc. (NMRA) Is One of the Best Get Rich Quick Stocks to Buy
07-07-2026
yahoo.com
Neumora Therapeutics (NMRA) Stock Sees Fair Value Falls After Navacaprant Discontinuation
11-07-2026
yahoo.com
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
27-07-2026
yahoo.com
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
14-08-2026
yahoo.com
Biotech Options Buzz: UTHR, NMRA, EWTX
18-09-2026
yahoo.com
What is the current price of NEUMORA THERAPEUTICS INC (NMRA:NASDAQ)?
The current price of NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) is $0.3681.
NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) since the previous trading day is $-0.0248.
NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) since the previous trading day is -6.312%.
What is the most recent average sentiment score for NEUMORA THERAPEUTICS INC (NMRA:NASDAQ)?
The most recent average sentiment score for NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) is 56 out of 100.
What is the most recent average sentiment for NEUMORA THERAPEUTICS INC (NMRA:NASDAQ)?
The most recent sentiment for NEUMORA THERAPEUTICS INC (NMRA:NASDAQ) is .
SEC-8K** Filing Available For NEUMORA THERAPEUTICS INC (NMRA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.